CClinicalTrials.gg
RecruitingNCT07081919Updated Jul 23, 2025

Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery

An observational study in Corneal Astigmatism and Cataract, sponsored by Eye & ENT Hospital of Fudan University. Recruiting at 1 site in China. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-23.

Sponsored by Eye & ENT Hospital of Fudan University · Observational

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
105
Ages
20 Years to 80 Years
Sex
All
01

Study summary

What is this study about? This study looks at whether a laser procedure called femtosecond laser-assisted arcuate keratotomy (FSAK) helps people with both cataracts and mild astigmatism see more clearly after cataract surgery. Astigmatism causes blurry vision because the front of the eye (cornea) is curved unevenly. The FSAK procedure uses a computer-guided laser to make tiny, precise cuts in the cornea during cataract surgery to fix this curve. the investigators want to see if this improves vision long-term (up to 5 years) and what factors affect how the investigatorsll it works.

Who can join? the investigators are looking for adults aged 20-80 years who:

Have cataracts and mild-to-moderate astigmatism (0.75-2.0 diopters) Plan to have cataract surgery Have not had prior eye surgeries (like LASIK) Do not have severe dry eye or other eye diseases (like glaucoma or retina problems) What will happen in the study?

Surgery: Participants will have cataract surgery combined with the FSAK procedure. The surgeon uses a laser to make tiny curved cuts in the cornea to reshape it.

Follow-up visits: Participants will have regular eye check-ups for 5 years after surgery. These include:

Vision tests (reading eye charts) Measurements of the eye's shape using painless imaging machines Questionnaires about vision quality and daily activities Time commitment: Visits happen at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. Each visit takes about 1-2 hours.

Why is this study important? FSAK may help people with astigmatism see clearly after cataract surgery without needing glasses as often. By tracking results for 5 years, the investigators'll learn how long the benefits last and who benefits most. This could help doctors better personalize treatment in the future.

Who is running the study? Eye doctors at Fudan University Eye \& ENT Hospital (Shanghai) and Shanghai Peace Eye Hospital. About 105 people will take part.

Read the detailed description

Study Description for General Audience

What's the problem? Many people with cataracts also have an irregularly curved front surface of the eye (called astigmatism). After cataract surgery, this astigmatism can still cause blurry or distorted vision, making everyday tasks like reading or driving difficult. While glasses or special lenses can help, many hope to reduce their dependence on them after surgery.

What's being tested?

This study evaluates a laser procedure called Femtosecond Laser-Assisted Arcuate Keratotomy (FSAK). During cataract surgery:

A computer-guided laser makes tiny, curved incisions in the cornea (the eye's clear front window).

These precise incisions gently reshape the cornea to improve its natural curve. Think of it like a sculptor smoothing uneven surfaces-but using light-speed technology.

Why is this study unique?

While FSAK isn't brand new, the investigators lack long-term data on:

How the investigatorsll it holds up over 5+ years. Which factors predict success (e.g., does participantsr eye's shape or pressure affect results?).

the investigators're following participants for 5 years to ansthe investigatorsr these questions-far longer than most existing studies.

What will participants experience?

Surgery: FSAK is combined with standard cataract removal. The laser step adds only minutes.

Follow-ups: Painless check-ups at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. These involve:

Reading eye charts. Quick scans to map the eye's surface. Short questionnaires about vision quality (e.g., glare at night or reading small print).

Why does this matter?

If successful, FSAK could:

  • Help people see clearly longer after cataract surgery.
  • Reduce the need for glasses or contacts.
  • Give doctors better tools to personalize treatment.

Who's involved?

Led by eye specialists at Fudan University Eye \& ENT Hospital and Shanghai Peace Eye Hospital.

02

Conditions studied

  • Corneal Astigmatism
  • Cataract

Keywords

  • femtosecond laser-assisted arcuate keratotomy
  • cataract surgery
  • corneal astigmtism
  • astigmatism treatment stability
  • predictors of surgical outcomes
03

In context

Astigmatism

413 studies on the registry are indexed under Astigmatism; 55 are open to participants now.

This study's planned enrollment of 105 is above the median of 93 across 84 observational studies indexed under Astigmatism.

Browse Astigmatism studies →

Lead sponsor

Eye & ENT Hospital of Fudan University is the lead sponsor of 121 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with regular corneal astigmatism of 0.75-2.0 D who plan to undergo cataract surgery.

Aged between 20 and 80 years old.

Inclusion criteria

  • Age: 20-80 years
  • Age-related cataracts
  • Regular corneal astigmatism (0.75-2.0 diopters) confirmed by Pentacam/IOLMaster 700
  • Surgical Plan: Scheduled for femtosecond laser-assisted cataract surgery
  • Central corneal thickness ≥500 µm
  • Endothelial cell count ≥2,000 cells/mm²
  • Best-corrected visual acuity (BCVA) improvable to ≥20/40

Exclusion criteria

Exclusion Criteria

  • Prior corneal refractive surgery (e.g., LASIK, PRK)
  • Intraocular surgery (e.g., glaucoma filtering surgery)
  • Irregular astigmatism (keratoconus, scarring, post-traumatic distortion)
  • Active ocular inflammation or infection
  • Corneal endothelial disease (e.g., Fuchs' dystrophy)
  • Severe dry eye (Schirmer test ≤5 mm/5 min)
  • Uncontrolled glaucoma (IOP >21 mmHg on medication)
  • Macular pathology (e.g., AMD, DME affecting visual potential)
  • Amblyopia
  • Autoimmune diseases affecting cornea (e.g., rheumatoid arthritis, Sjögren syndrome)
  • Diabetes mellitus with retinopathy
  • Pregnancy/Lactation
  • Inability to complete 5-year follow-up
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
105 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • FSAK with Cataract Surgery

    Participants in this group undergo femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery

    Procedure: femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery

Interventions

  • Procedurefemtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery

    1. 5-year follow-up assessing stability of astigmatism correction. Most FSAK studies track ≤2 years. This addresses critical evidence gaps in durability 2. Combines topographic data with patient-reported visual function (VF-14/QoV questionnaires at all visits. Links anatomical changes to real-world visual experiences

06

What researchers measure

Primary outcomes

  1. Change in corneal astigmatism magnitude (diopters) from baseline

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Secondary outcomes

  1. Visual Acuity-UCVA

    Uncorrected Distance Visual Acuity (UDVA) at 5m (logMAR)

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  2. Visual acuity-BCVA

    Best-Corrected Visual Acuity (BCVA) at 5m (logMAR)

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  3. Manifest refraction spherical equivalent (MRSE) in Diopter (D)

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  4. Corneal Topography

    Corneal Topography assesses corneal curvature, with data collected using the Pentacam instrument and IOL Master. The measured outcome reflects the corneal's refractive power and shape characteristics. Corneal curvature is reported in diopters (D) , a standard unit for quantifying refractive power in ophthalmic measurements.

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  5. Objective Optical Quality

    Objective visual quality is evaluated by measuring Total ocular higher - order aberrations (HOAs, unit: µm) and Strehl ratio (SR) using the iTrace instrument. Total ocular higher - order aberrations reflect the deviation of the eye's optical system from an ideal state, where higher values generally indicate greater optical imperfections that may disrupt visual clarity. The Strehl ratio, on the other hand, quantifies the quality of optical imaging; a higher SR (ranging from 0 to 1, with 1 representing ideal optical quality) signifies better visual quality, as it relates to the concentration of light in the retinal image. These metrics, derived from iTrace measurements, provide objective assessments of how well the eye processes visual input, crucial for evaluating surgical outcomes (e.g., cataract or refractive surgery) and ocular health.

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  6. Patient-Reported Outcomes

    bjective visual quality can be assessed with the Visual Function-14 (VF-14) questionnaire, which evaluates 14 vision-dependent daily activities. Patients self-rate their functional limitations, with scores ranging from 0 (worst) to 100 (best), where higher scores indicate better visual function. It is administered preoperatively and 3 months postoperatively to measure changes, with a minimal clinically important difference of 15.57, meaning a score change exceeding this value signifies a meaningful improvement The DOI of reference for visual function questionnaire is 10.1016/j.ophtha.2010.04.009.

    Time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

07

Study locations

1 of 1 sites recruiting
  • Eye and Ear, Nose, and Throat Hospital of Fudan University
    Shanghai, Shanghai Municipality 200031, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Data contain sensitive biometric identifiers (e.g., corneal topography maps) that cannot be fully de-identified

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07081919
Lead sponsor
Eye & ENT Hospital of Fudan University
Responsible party
Jin Yang (Chief Physician, Eye & ENT Hospital of Fudan University) — Principal investigator
First posted
Jul 23, 2025
Start date
Apr 22, 2025
Primary completion
Apr 22, 2030 (estimated)
Completion
Apr 22, 2031 (estimated)
Last update
Jul 23, 2025

Study contacts

Jin Yang, PhD
Contact
jin_er76@hotmail.com
13671632525

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion